ONCONOVA THERAPEUTICS, INC.

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2001–2016

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2016	—	1	1
2015	—	4	1
2014	—	4	1
2013	—	5	1
2012	—	4	1
2011	—	4	1
2010	—	4	1
2009	—	8	2
2008	—	8	2
2007	—	4	2
2006	—	2	2
2005	—	4	2
2004	—	5	2
2003	—	3	2
2002	—	5	2
2001	—	1	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
HIRSCHBERG, P.C.	—	22
AMERICAN DEFENSE INTERNATIONAL INC	—	44

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	52
HOUSE OF REPRESENTATIVES	51
Defense, Dept of (DOD)	14
Nuclear Regulatory Commission (NRC)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Defense	Defense	57
Health Issues	Health Issues	4

Bills Explicitly Cited (1)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2647110th Congress

Mental Health and Substance Abuse Juvenile Services Improvement Act of 2007

2010 · first_quarter · Firm: AMERICAN DEFENSE INTERNATIONAL INC

Open original LDA filing ↗

Cited source text and reported amounts

Department of Defense Appropriations Bill, provisions relating to medical research. National Defense Authorization Act (HR2647), provisions relating to medical research.

Client expense: — · Firm income: $10,000

Matched citations: HR2647

Source: Senate LDA

ONCONOVA THERAPEUTICS, INC. — Lobbying Disclosure | Poliscope